Bank OZK Reduces Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Bank OZK lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 14.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 732 shares of the healthcare conglomerate’s stock after selling 121 shares during the quarter. Bank OZK’s holdings in UnitedHealth Group were worth $370,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. AMF Tjanstepension AB grew its holdings in UnitedHealth Group by 88.0% in the 3rd quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock valued at $151,374,000 after buying an additional 121,180 shares during the period. Hudson Value Partners LLC grew its holdings in UnitedHealth Group by 8.3% in the 3rd quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock valued at $625,000 after buying an additional 82 shares during the period. Wealth Group Ltd. lifted its stake in shares of UnitedHealth Group by 4.0% in the 3rd quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock valued at $1,039,000 after purchasing an additional 68 shares in the last quarter. Howard Capital Management Group LLC acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $341,000. Finally, GSG Advisors LLC lifted its stake in shares of UnitedHealth Group by 14.4% in the 3rd quarter. GSG Advisors LLC now owns 746 shares of the healthcare conglomerate’s stock valued at $435,000 after purchasing an additional 94 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. 0.33% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Barclays reduced their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Finally, Wells Fargo & Company reduced their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Trading Up 1.4 %

NYSE UNH opened at $474.95 on Friday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a 50-day simple moving average of $516.59 and a 200-day simple moving average of $557.16. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market capitalization of $437.09 billion, a PE ratio of 30.64, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the business posted $5.83 EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.77%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.